“A Reduced Fixed Dose of Tocilizumab 200 Mg Compared to 400 Mg in Patients With Severe COVID-19 Disease”. One Health & Risk Management , vol. 4, no. 4, Sept. 2023, pp. 19-26, https://doi.org/10.38045/ohrm.2023.4.02.